Bipolar Disorder or Schizophrenia |
1.23 |
8 |
4 |
8.9 |
0.73 |
1.0e-02 |
AC074117.10 FES KLC1 NDUFA6-AS1 PPP1R13B RP11-73M18.8 THOC7 XRCC3 |
Depressed Affect (Nagel 2018) |
1.19 |
11 |
6 |
13.3 |
0.23 |
4.7e-01 |
AATK AC009228.1 ARHGAP27 FNBP4 MST1R MTCH2 PPTC7 RP5-1115A15.1 THRA TTC19 WNT3 |
Depression (Nagel 2018) |
1.17 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
AATK RP5-1115A15.1 |
Intelligence (Savage-Jansen 2018) |
1.17 |
15 |
8 |
17.8 |
-0.40 |
1.1e-01 |
ARHGAP27 C1QTNF4 CENPW CGREF1 DCAF16 ERAP2 FNBP4 HSD17B3 MARK3 MST1R MTCH2 NPIPB6 RP11-73M18.8 SREBF1 UBXN2A |
Neuroticism (Nagel 2018) |
1.09 |
12 |
9 |
20.0 |
0.22 |
4.9e-01 |
AATK AHSA2 ARHGAP27 CENPW CTC-498M16.2 FNBP4 MTCH2 PTCH1 RP5-1115A15.1 SETD1A THRA WNT3 |
Schizophrenia (2018) |
1.25 |
6 |
5 |
11.1 |
0.57 |
1.4e-01 |
FES KLC1 NDUFA6-AS1 RP11-73M18.8 THOC7 XRCC3 |
Schizophrenia vs Biploar Disorder |
1.27 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PPTC7 |
Worry (Nagel 2018) |
1.12 |
10 |
8 |
17.8 |
-0.04 |
9.0e-01 |
AATK AHSA2 ARHGAP27 CENPW CTC-498M16.2 FNBP4 MTCH2 PTCH1 RP11-78O7.2 SETD1A |
Alzheimer’s Disease (in mother) |
1.39 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
APOC1 PVRL2 |
Alzheimer’s Disease (in father) |
1.19 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
APOC1 PVRL2 |
Alzheimer’s Disease (including proxy) |
1.91 |
10 |
7 |
15.6 |
-0.33 |
3.5e-01 |
AC011558.5 APOC1 BCKDK CKM MS4A2 NDUFS2 PTK2B PVR PVRL2 SETD1A |
Crohns Disease (2017) |
1.99 |
31 |
26 |
57.8 |
-0.18 |
2.9e-01 |
ABCA7 AC004041.2 AC074117.10 ADCY7 ADO AHSA2 CCDC116 CDKN2D CENPO CPEB4 DCLRE1B ERAP2 FADS1 FADS2 FNDC4 GSDMB HEATR3 ITGA4 NDFIP1 NPIPB6 PDLIM4 PGAP3 POLR2E RP11-373D23.3 RP11-429P3.3 SDCCAG3 SLC22A4 STARD3 STMN3 TSPAN14 UQCRQ |
Irritable Bowel Disease (IBD) |
1.83 |
30 |
24 |
53.3 |
-0.04 |
8.2e-01 |
ABCA7 AC004041.2 AC074117.10 ADO AHSA2 ATF6 CCDC116 CDKN2D CENPO CPEB4 ERAP2 FNDC4 GSDMB MST1R NDFIP1 NPIPB6 PDLIM4 PGAP3 POLR2E RGS14 RP11-373D23.3 SDCCAG3 SHISA5 SLC22A4 STARD3 STMN3 TCTEX1D1 TSPAN14 UQCRQ ZHX3 |
Ulcerative Colitis (UC) |
1.35 |
12 |
8 |
17.8 |
-0.30 |
3.5e-01 |
AHSA2 ATF6 GNA12 GSDMB ITGAL MST1R NPIPB6 RGS14 SDCCAG3 SHISA5 STMN3 THRA |
Major Depression (MDD) |
1.31 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP11-73M18.8 |
Reaction Time |
1.21 |
7 |
3 |
6.7 |
0.12 |
8.0e-01 |
AC009228.1 ITSN2 JMJD6 LOC375190 RMI1 SH2B3 SREBF1 |
Verbal and Numeric Reasoning (VNR) |
1.17 |
8 |
4 |
8.9 |
-0.77 |
2.7e-02 |
C1QTNF4 DCAF16 FADS2 MST1R MTCH2 NPIPB6 RP11-73M18.8 SREBF1 |
Breast Cancer |
1.34 |
22 |
14 |
31.1 |
0.35 |
8.5e-02 |
AC000120.7 ARHGAP27 CASP10 CCR5 CDKN2B CENPO CORT DCLRE1B FES HSF2 IMP3 KRIT1 LRRC25 MAN2C1 NEK10 NUDT14 PDLIM4 PHTF1 PTPN22 RIN3 RP11-73O6.3 UQCRQ |
Ovarian Cancer |
1.02 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABO ARHGAP27 |
Prostate Cancer |
1.29 |
4 |
3 |
6.7 |
0.49 |
5.1e-01 |
RP11-554A11.9 RPN1 TH TTLL12 |
Age at First Birth |
1.18 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
MST1R TRAF3 |
Body Mass Index (BMI) (2010) |
1.23 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
C1QTNF4 NPIPB6 |
Coronary Artery Disease (CAD) |
1.54 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
ABO CDKN2B SREBF1 |
Crohns Disease (2012) |
1.67 |
12 |
10 |
22.2 |
-0.63 |
2.0e-02 |
AC004041.2 ADCY7 ADO ERAP2 FADS1 GSDMB MST1R NDFIP1 PDLIM4 SLC22A4 STMN3 UQCRQ |
Fasting Glucose |
1.72 |
8 |
7 |
15.6 |
-0.58 |
1.0e-01 |
AC074117.10 C11orf10 FADS1 FNDC4 G6PC2 GCKR NOSTRIN NRBP1 |
HbA1C |
1.25 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CD46 |
HDL Cholesterol |
1.88 |
22 |
20 |
44.4 |
-0.34 |
9.3e-02 |
ACP2 C11orf10 C1QTNF4 C6orf106 CCDC116 CCDC92 CDK2AP1 FADS1 FADS2 FNBP4 GSDMB MLXIPL MTCH2 NLRC5 NRBF2 PGAP3 PPP1R32 RP11-138A9.1 RP11-214K3.24 RP11-380L11.3 SLC39A13 STARD3 |
LDL Cholesterol |
2.10 |
15 |
12 |
26.7 |
-0.24 |
3.2e-01 |
ABO APOC1 ATP13A1 C11orf10 CACFD1 EVI5 FADS1 FADS2 PPP1R32 PVR PVRL2 SH2B3 SIDT2 STXBP3 TIMD4 |
Lupus |
1.42 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
C17orf37 CCDC116 PHRF1 |
Neuroticism (2016) |
1.11 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ARHGAP27 |
Primary Biliary Cirrhosis |
1.37 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
GSDMB SH2B3 STARD3 |
Rheumatoid Arthritis |
2.11 |
7 |
4 |
8.9 |
-0.32 |
3.7e-01 |
DCLRE1B FADS2 OLFML3 PHTF1 PTPN22 SH2B3 TRAF1 |
Schizophrenia (2014) |
1.22 |
9 |
5 |
11.1 |
0.60 |
5.3e-02 |
CCDC92 FES KLC1 NDUFA6-AS1 PPP2R3C RP11-73M18.8 SMG6 SREBF1 XRCC3 |
Triglycerides |
3.24 |
24 |
21 |
46.7 |
0.38 |
4.9e-02 |
AC074117.10 APOC1 ATP13A1 BCKDK C11orf10 CAD CCDC92 CGREF1 FADS1 FADS2 FNDC4 GCKR GPN1 HSD17B11 MLXIPL NRBF2 NRBP1 PPP1R32 RP11-214K3.24 RP11-380L11.3 SETD1A SIDT2 SNX17 TIMD4 |
Type 2 Diabetes (T2D) (2012) |
1.39 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
BZRAP1 |
Ulcerative Colitis |
1.40 |
6 |
1 |
2.2 |
-0.04 |
9.3e-01 |
AHSA2 ATF6 GNA12 GSDMB SDCCAG3 STMN3 |
Blood Eosinophil Count |
3.40 |
189 |
149 |
331.1 |
0.63 |
2.5e-25 |
ABCA7 ABCC5 ABO AC004041.2 AC010883.5 AC034220.3 AC074117.10 AC084018.1 ACAP1 ACAT1 ACBD5 ADAM1A ADAMTSL4 ADO ADRB2 AHSA2 AK3P3 AK9 AP000351.10 APBB1IP APOC1 ARHGAP27 ARRB2 ARVCF ATF1 ATG14 AUH BACH2 BCKDK BID BRD3 C11orf10 C11orf21 C12orf52 C17orf37 C19orf44 C1orf38 C22orf45 C3orf34 C5orf34 C7orf40 CACFD1 CACNA1H CALCRL CCDC116 CCDC9 CD33 CDK2AP1 CDK6 CECR6 CENPO CEP19 CHD7 CHERP CKM CORO7 CTD-2033A16.3 CUX2 CXCL12 CYP8B1 DEXI DOK6 EBPL EHD4 EIF1AD EOMES ERCC2 FADS1 FADS2 FAM84B FBF1 FBXO38 FKBP5 FLJ13197 FLJ33630 FRAT2 GATAD1 GCKR GGT5 GSK3A GSTT1 H2AFV HBS1L HMG20A IFITM2 IFITM3 IFNG IKZF2 ITGAL KRIT1 LAPTM5 LEPR LETMD1 LIMK2 LINC00854 LOC90246 LY75 MAN1B1 MAP4K4 MAPKAPK5 MARK4 MAX MED24 MKRN2 MPP2 MRPS21 MSL1 MST1R MVK MYRF NDFIP1 NDUFS2 NFKBIA NOSTRIN NR1D1 NUCB2 OAS1 P2RX4 PAK2 PARP12 PDE8B PDLIM4 PEX7 PIAS1 PIK3CD POLI PPOX PPP1R32 PPTC7 PRTFDC1 PRUNE PVT1 RAB7A RBBP8 RBPMS RCBTB1 REST RGS14 RIN3 RMI1 RND2 RNF181 RP11-138A9.1 RP11-347C12.1 RP11-347C12.2 RP11-54A4.2 RP3-462E2.3 RP3-462E2.5 RP4-549L20.3 RP5-1029K10.2 RP5-1115A15.1 RPN1 RTF1 SDCCAG3 SELL SH2B3 SIDT2 SIGLEC14 SLC22A4 SLC39A13 SPECC1L SPRED2 SREBF1 ST20 STXBP6 SURF1 SURF6 TBX6 TCEA3 TCTN1 THAP9-AS1 THRA TMED8 TMEM116 TMEM150C TNFRSF10B TNFRSF1A TRERF1 TRIB2 TSEN2 UQCRQ VLDLR VPS29 WAC-AS1 WNT3 ZFP36L1 ZNF292 ZNF785 ZNF786 |
Blood Platelet Count |
2.97 |
235 |
201 |
446.7 |
0.45 |
1.2e-15 |
ABCA7 ABCC5 AC004041.2 AC010883.5 AC034220.3 AC074117.10 AC084018.1 ACAP1 ACAT1 ACBD5 ACP2 ADAM1A ADO AK9 ALDH8A1 AP3D1 APOC1 ARHGAP15 ARHGAP27 ARRB2 ARVCF ATF1 ATP13A1 BCAR3 BRD3 BRF1 BTBD6 BZRAP1-AS1 C11orf10 C12orf52 C18orf8 C1orf38 C1QTNF4 C3orf34 C4orf44 C6orf106 C7orf40 CACFD1 CAD CASP10 CAV2 CCM2 CD164 CD300LF CD33 CD46 CDK2AP1 CDK6 CDKN1B CDKN2B CERS5 CKM CNN2 CORO7 CTA-85E5.10 CUX2 DCAF16 DHRS13 DOCK10 DOK6 DSTYK EDEM3 EEPD1 EHD4 EIF1AD EMID1 ENO1 EOMES ERCC2 ETS1 EVI5 FADS1 FADS2 FAM170B FAM65C FLJ13197 FLJ43663 FNDC4 FRAT2 GALNT1 GATAD1 GCKR GNA12 GP1BA GPN1 GRK4 GSK3B H2AFV HAUS8 HBS1L HEATR3 HELLS HSD17B11 HSD17B3 HSF2 IFITM2 IFITM3 IFNG IL1RN IMP3 IPPK KANSL2 KIAA1614 KRIT1 LARP4 LEPR LMNA LOC90246 MAN2C1 MAP1S MAP3K3 MAP4K4 MAPKAPK5 MARK4 MAX MBOAT7 MED24 MEG3 MKRN2 MLXIPL MPP2 MTCH2 NACAD NCK1 NDFIP1 NDUFS2 NEK10 NEK6 NINJ2 NLRP3 NPIPB6 NRBF2 NRBP1 NUDT14 OAS1 ORAOV1 PAK2 PAQR8 PARP12 PDLIM4 PEX7 PFN1 PGAP3 PHRF1 PIPSL PKN3 PLA2R1 PNKD PPAPDC2 PPCDC PPP1R32 PPT1 PPTC7 PRTFDC1 PTPMT1 PVR RABEP1 RAI14 RBPMS RCBTB1 REST RIN3 RIOK1 RMI1 RP1-102E24.8 RP11-429P3.3 RP11-554A11.9 RP11-567L7.5 RP11-78O7.2 RP3-462E2.3 RP3-462E2.5 RP5-1029K10.2 RPL12 RPS10 RPS6KB1 RRP12 RSU1 RTN4RL1 S1PR3 SAAL1 SCN11A SEC1 SEPT12 SETDB2 SGCD SH2B3 SIDT2 SLC22A4 SLC25A1 SLC39A13 SLC44A2 SMG5 SMG6 SNX1 SNX17 SPC25 SSH2 ST5 STARD3 STMN3 STXBP6 SURF6 TADA2A TAF8 TBRG4 TCTN1 TGM2 TGOLN2 THAP9-AS1 TIMD4 TIPARP TMEM136 TMEM68 TNFRSF1A TPM2 TRAF1 TRAF3 TRAF3IP3 TRIB2 TRIT1 TSEN2 TTLL12 UBASH3B UQCRQ USP37 VLDLR VPS13B VPS29 VPS9D1 WNT3 YWHAE ZC3HAV1L ZHX3 ZNF76 ZNF785 |
Blood Red Count |
2.53 |
155 |
125 |
277.8 |
0.51 |
2.2e-13 |
ABCC5 ABO AC000120.7 AC005702.4 AC009228.1 AC010883.5 AC074117.10 AC084018.1 ACAT1 ADAM1A AHI1 AK1 AK9 ALDH8A1 AP3D1 ARHGAP27 ATP13A1 BACH2 BCKDK BRD3 BRF1 BTBD6 C11orf10 C11orf21 C12orf29 C17orf46 C18orf25 C19orf44 C1orf38 CACFD1 CBX7 CCDC92 CCR5 CD164 CENPW CKM CNIH4 CSNK1G1 CTC-498M16.2 CUX2 CYB5D1 DEGS1 DHRS13 DSTYK EHD4 EIF1AD FADS1 FADS2 FAM65C FBLN7 FLJ13197 FNBP4 FNDC4 FTH1P20 GCKR GUSBP3 H2AFV HBS1L HELLS HMG20A HSD17B11 IFITM3 IMP3 ITGAL ITSN2 KIF20B KLC1 KLHL5 KRIT1 LTK MAP3K3 MARK3 MAST2 MAX MBLAC1 MBOAT7 MEG3 MITF MYRF NDFIP1 NPIPB6 NRBF2 PAWR PCGF3 PDLIM1 PFAS PFN4 PGAP3 PKN3 PMS2CL POLI POLR2E PPAPDC2 PPOX PPP1R32 PPTC7 RAI14 RGS14 RIC8B RNFT1 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP11-73O6.3 RP3-388E23.2 RP3-462E2.5 RPS6KB1 RSPH10B2 RTF1 SARDH SDCCAG3 SETD1A SH2B3 SLC12A7 SLC23A3 SLC2A1 SLC9A3R2 SMG6 SMG9 SNX1 SPPL2A SPTBN1 SREBF1 SSH2 ST5 STARD3 SURF1 SURF6 TADA2A TAF8 TBX6 TCEA3 TFEB THAP9-AS1 TIE1 TIPARP TMCO3 TMEM116 TMEM150C TMEM87B TRAF3 TRAF3IP3 TRERF1 TRIB2 TSHR UBE2E3 VPS13B VPS29 VPS9D1 WNT3 XRCC3 YWHAE ZFAND4 ZNF785 |
Heel T-Score |
1.78 |
118 |
92 |
204.4 |
0.02 |
7.9e-01 |
ABO AC005702.4 ACP2 ADCK3 AP3D1 ARHGAP27 BCKDK C11orf10 C7orf40 CACFD1 CALCRL CASKIN1 CCDC116 CCDC92 CD164 CDK5RAP3 CDK6 CERS5 CMIP CNIH4 CORO7 CTA-85E5.10 CYB5D1 DCAF16 DIP2B DOCK8 EBPL ENO1 ERCC2 ETHE1 EVI5 FADS1 FADS2 FAM170B FBLN7 FLJ33630 FLNB FTH1P20 GATAD1 GNA12 GRIN3B HSD17B11 IFITM3 IPPK IQGAP1 ITGA4 KANSL2 KIAA1614 KLC1 KRIT1 LARP4 LINC00854 MAP1S MAP3K3 MPP2 MRPS21 MS4A2 MST1R NBEAL2 NIPSNAP1 NUDC PCGF3 PHLDB3 PINLYP PNKD PPP1R13B PPP1R32 PTPMT1 PTPN23 REST RFT1 RIN3 RMI1 RND2 RNF212 RP11-214K3.24 RP11-326C3.11 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP11-440L14.1 RP11-554A11.9 RP11-73M18.8 RP11-73O6.3 RP5-1115A15.1 RPS10 SCAP SCIMP SETD1A SETDB2 SLC35E1 SLC39A13 SLC9A3R2 SMG6 SPTBN1 SSH2 ST5 SUPT3H SURF1 SURF6 SV2A TCTEX1D1 TIPARP TMEM87B TPCN2 TPM2 TRIB2 TSEN2 TSPAN14 TTLL12 TUBG2 UBE2E3 VPS13B WDFY2 XRCC3 ZHX3 ZNF366 ZNF76 |
BMI |
1.35 |
74 |
53 |
117.8 |
0.07 |
5.6e-01 |
AC074117.10 ACP2 ANTXR2 BCKDK BTBD7 C14orf142 C18orf8 C1QTNF4 C6orf106 CDK5RAP3 CENPO CKM CLUAP1 CTC-498M16.2 CTD-2033A16.3 DCAF16 EDEM3 EIF2S2 EVI5 FNBP4 FNDC4 GCKR GFPT1 GP1BA GRK4 H2AFV HMG20A ITGAL KAT2B KLC1 MAP3K3 MARS2 MED24 MINK1 MLXIPL MRPS21 MST1R MTCH2 NCK1 NOP14 NPIPB6 NRBF2 ORAOV1 PAM PDE4B PFN1 PPP1R13B PPTC7 PRUNE RABEP1 RCN2 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP11-395P17.3 RP11-73O6.3 RPN1 RPS10 RTN4RL1 SETD1A SLC5A11 SLC9A3R2 SMG6 SSH2 TBX6 THRA TRAF3 TTC19 UBASH3B UNC5CL WWP1 XRCC3 ZKSCAN5 |
Height |
1.86 |
217 |
180 |
400.0 |
-0.33 |
5.1e-08 |
AATK ABO AC004041.2 AC009228.1 AC010883.5 AC034220.3 AC074117.10 ACP2 ADO AK3P3 AK9 ANKRD17 ANTXR2 AP3D1 APOC1 ARHGAP27 ASPRV1 ATF1 ATG14 ATP13A1 BRD3 C11orf10 C18orf8 C19orf66 C1QTNF4 C4orf44 C6orf106 C7orf40 CACFD1 CACNA1H CASKIN1 CBX7 CCDC126 CCDC92 CCT6A CD46 CDADC1 CDK2AP1 CDK6 CDKN1B CENPO CENPW CERS5 CGREF1 CHD7 CNIH4 CTD-2033A16.3 CUX2 DCAF16 DLEU7 DNAJC13 DZIP1 EBPL EDEM3 EIF1AD ETHE1 ETS1 EVI5 FADS1 FADS2 FER FES FLJ13197 FLJ33630 FNBP4 FNDC3B FNDC4 G6PC2 GALNT1 GATAD1 GCKR GNA12 GSK3A HDAC3 HMG20A HOMEZ HSD17B3 IMP3 IPPK ITSN2 JAZF1 KANSL2 KIAA1614 KLC1 KLHL18 KLHL5 KRIT1 LARP4 LETMD1 LMNA LOC375190 LYZ MAN2C1 MAP1S MAP3K3 MAP4K4 MAPKAPK5 MARK3 MARS2 MAX MED24 MEG3 MIER1 MINK1 MKRN2 MLXIPL MRPS21 MSL1 MTCH2 MYBL2 NAP1L4 NBEAL2 NCK1 NEK10 NFKBIA NIPSNAP1 NOP14 NOSTRIN NRBF2 NRBP1 NUCB2 NUDC PAM PAQR8 PARP12 PAX8 PCDHB16 PDLIM4 PFN4 PGAP3 PHLDB3 PINLYP PLXND1 PNKD PPCDC PPP1R13B PPTC7 PRTFDC1 PRUNE PTCH1 PTPMT1 RAB5C RAPGEFL1 RASL11A RBBP8 RBPMS RCBTB1 RCN2 REST RFT1 RGS14 RIC8B RMI1 RNF181 RP11-214K3.24 RP11-373D23.3 RP11-380L11.3 RP11-554A11.9 RP11-73M18.8 RP11-73O6.3 RP11-864G5.3 RP13-39P12.3 RP3-462E2.3 RP5-1029K10.2 RP5-1115A15.1 RPS10 RTF1 SAAL1 SCAP SDCCAG3 SEC1 SEPT12 SETDB2 SH2B3 SLC22A4 SLC23A3 SLC25A1 SLC39A13 SLC4A4 SLC9A3R2 SNORD124 SNX17 SPC25 SPPL2A SPRED2 SREBF1 SSH2 ST3GAL6-AS1 STARD3 SUPT3H TBC1D14 TBRG4 TH THOC7 THRA TIE1 TMED2 TMEM181 TNKS2 TPCN2 TRPM7 TSEN2 TULP3 TULP4 UBE4B UBXN2A UQCRQ USP37 VPS9D1 WAC-AS1 WNT3 XRCC3 YWHAE ZKSCAN5 ZNF575 ZNF76 ZNF786 |
Waist Hip Ratio (WHR) |
1.83 |
55 |
42 |
93.3 |
0.55 |
5.6e-06 |
ADAM1A AMPD3 AP3D1 APOC1 ARHGAP27 AUH BCAR3 C4orf44 C6orf106 CALCRL CCDC92 CDKN1B CENPW CMIP CORO7 CPLX1 DMXL1 DSTYK EBPL EHD4 FAM100B FBF1 FLJ33630 GTF2H3 HAUS8 HOXC6 IPPK LIMK2 LPAR1 LTK MAN2C1 MKRN2 MLXIPL NBEAL2 NDST1 NDUFS2 ORAOV1 PAM PTPN23 RFT1 RIC8B RP11-138A9.1 RP11-214K3.24 RP11-380L11.3 RP11-440L14.1 RP11-73O6.3 SCAP SEC1 SLC39A13 SREBF1 SSPN TIPARP TMED2 TSEN2 WNT3 |
Systolic Blood Pressure |
1.59 |
79 |
53 |
117.8 |
0.32 |
1.4e-03 |
ABCC5 AC010883.5 ADAM1A ARHGAP27 ARHGAP42 ARVCF ATF1 ATP13A1 CCT6A CD46 CDK6 CDKN1B CENPO CERS5 CMIP CORO7 CYB5D1 DCAF16 DMXL1 DNAJC12 EHD4 FBF1 FBLN7 FBXO38 FER FES FLJ33630 FNBP4 FTH1P20 GATAD1 GFPT1 GPN1 HAUS8 HELLS HOXC6 KRIT1 LA16c-358B7.3 MAPKAPK5 MTCH2 NEK10 NEK6 NFKBIA NUCB2 PAWR PCDHB16 PFKFB2 PIPSL POLI PPTC7 RASL11A RIN3 RP11-138A9.1 RP11-373D23.3 RP11-78O7.2 RP3-462E2.3 RP3-462E2.5 RP5-1029K10.2 RP5-1115A15.1 RPS6KB1 RTF1 SEPT12 SGCD SH2B3 SIDT2 SLC39A13 SLC45A4 SLC5A11 SLC9A3R2 SREBF1 THAP9-AS1 TIE1 TM7SF3 TMEM116 TMEM87B TRPM7 UBE2E3 UBXN2A VPS29 YWHAE |
Smoking Status |
1.24 |
11 |
1 |
2.2 |
0.31 |
3.4e-01 |
AC139100.3 ADAM1A CTD-2033A16.3 PDE4B PGAP3 PHTF1 RP11-73M18.8 RP5-1115A15.1 STARD3 UBE2E3 ZKSCAN5 |
Allergy or Eczema |
1.99 |
43 |
32 |
71.1 |
0.14 |
3.4e-01 |
ABO AC074117.10 ADAM1A AHI1 AHSA2 ARHGAP15 BACH2 C17orf37 C17orf46 C3orf34 C6orf106 CCDC116 CD300LF DEXI EIF1AD ENO1 FAM117B GSDMB HDAC3 IFITM2 IQGAP1 MED24 MIER1 MRPL4 MSL1 NDFIP1 PDLIM4 POLI PRUNE RGS14 RIN3 RP3-388E23.2 RP5-1029K10.2 RP5-1115A15.1 RTF1 SREBF1 STARD3 STMN3 THRA TRAF1 TRAF3 TUBG2 UQCRQ |
Cardiovascular Disease |
1.63 |
50 |
29 |
64.4 |
0.57 |
1.2e-05 |
AC004041.2 AC006111.1 AC010883.5 AC074117.10 ACP2 ADAM1A ARVCF BCKDK C18orf8 C4orf44 CMIP DCAF16 DMXL1 EHD4 FBF1 FBLN7 FES FNDC4 GATAD1 GCKR GPN1 GRK4 HAUS8 HELLS HOXC6 KLC1 LA16c-358B7.3 LYZ MAP3K3 MLXIPL MOBP NEK10 NFKBIA NUCB2 PTPMT1 PVRL2 RP11-138A9.1 RP3-462E2.5 RP5-1029K10.2 RP5-1115A15.1 RTF1 SETD1A SH2B3 SIDT2 SLC22A4 SLC39A13 TMEM116 TMEM87B UBASH3B YWHAE |
Hypothyroidism (self reported) |
2.58 |
34 |
27 |
60.0 |
0.37 |
1.0e-02 |
AC009506.1 ACAP1 ADAM1A AHI1 BACH2 BAZ2B C11orf10 C12orf52 C17orf37 CHD7 CUX2 DCLRE1B DOK6 DPP4 FADS1 FADS2 MAPKAPK5 OLFML3 PHTF1 PKN3 PPP1R32 PTPN22 PVT1 RAB2A RP11-326C3.11 RP3-388E23.2 RP3-462E2.3 RP5-1115A15.1 SH2B3 SIDT2 TCTN1 TMEM116 UBE2E3 VPS29 |
Respiratory disease |
2.16 |
26 |
24 |
53.3 |
0.57 |
1.9e-04 |
AC004041.2 AHI1 BACH2 C11orf10 DEXI ENO1 FADS1 FADS2 GSDMB MED24 MSL1 NDFIP1 PDLIM4 PGAP3 PPP1R32 RGS14 RIN3 RP3-388E23.2 RP5-1029K10.2 RP5-1115A15.1 RTF1 SLC22A4 STARD3 THRA UQCRQ ZNF76 |
Type 2 Diabetes (T2D) (2018) |
1.53 |
8 |
3 |
6.7 |
-0.15 |
7.1e-01 |
AC074117.10 FNDC4 GCKR HMG20A MAN2C1 MST1R RP11-138A9.1 TNKS2 |
Lung FEV1/FVC ratio |
1.42 |
57 |
44 |
97.8 |
-0.16 |
2.1e-01 |
ABO AC009506.1 ADAM33 AHSA2 ARHGAP42 BACH2 BAZ2B C19orf54 C6orf106 CALCRL CCDC69 CDK5RAP3 CENPO CENPW CEPT1 CTA-85E5.10 EHD4 EVI5 FBXO38 FLJ33630 GNA12 GSDMB HELLS HOXC6 IFITM2 IFITM3 ITGA2 KLF6 MARS2 MAST2 MSL1 NFKBIA NRBF2 PDE8B PDLIM4 PTCH1 PTPN23 RAB7A RAI14 RCN2 RGS14 RP11-326C3.11 RP11-347C12.2 RP5-1029K10.2 RPN1 SETD1A SLC22A4 SMG6 SMUG1 SNRPF SPPL2A SREBF1 SSH2 ST5 TSPAN14 UQCRQ ZNF76 |
Lung FVC |
1.50 |
63 |
43 |
95.6 |
-0.18 |
1.0e-01 |
ABO AC084018.1 ADAMTSL4 ADCY7 AHI1 ARHGAP27 ATF1 BCKDK BTBD7 C18orf8 C5orf34 C6orf106 CCDC126 CDK5RAP3 CENPW CERS5 CHD7 CLUAP1 CNIH4 CTB-36H16.2 CTD-2033A16.3 DCAF16 DNAJC13 DSTYK EBPL EIF2S2 FLJ33630 GFPT1 GRK4 GSK3A GSK3B HOXC6 KIAA1614 LARP4 LEPR LTK MAN2C1 MRPS21 NOP14 NPIPB6 NRBF2 PDLIM4 PGAP3 PTCH1 RIN3 RP11-54A4.2 RP3-388E23.2 RSPH10B2 RTF1 SDCCAG3 SETD1A SETDB2 SLC22A4 SREBF1 STARD3 STMN3 SV2A TTC19 TULP4 UBXN2A WNT3 YWHAE ZNF12 |
Neuroticism |
1.12 |
12 |
6 |
13.3 |
0.31 |
3.2e-01 |
AATK AHSA2 ARHGAP27 CENPW FNBP4 MTCH2 PTCH1 RP5-1115A15.1 SETD1A ST8SIA4 THRA WNT3 |
Chronotype (morning person) |
1.08 |
4 |
4 |
8.9 |
0.51 |
3.8e-01 |
MRPS21 RMI1 RP11-54A4.2 SDCCAG3 |
Hair Pigment |
1.09 |
42 |
32 |
71.1 |
-0.08 |
5.8e-01 |
AC074117.10 ACP2 ARVCF C11orf10 C12orf29 CNN2 CORT DENND1A DSTYK EIF2S2 EOMES FADS1 FADS2 FES FLJ43663 FNDC4 GPN1 IFITM3 IL16 KLC1 LYST MAPKAPK5 MSL1 NRBP1 NUCB2 PPP1R13B RP11-373D23.3 RP11-554A11.9 RP11-73M18.8 RP11-73O6.3 RP3-462E2.3 RP5-1115A15.1 SH2B3 SLC39A13 SNX17 TPCN2 TRAF1 TULP4 VPS9D1 WNT3 XRCC3 ZNF76 |
Tanning |
1.11 |
15 |
9 |
20.0 |
0.10 |
7.3e-01 |
AC074117.10 ADO CORO7 DSTYK EIF2S2 FNDC4 GCKR LEPR MLXIPL PDE4B RP11-373D23.3 RP11-554A11.9 SH2B3 TPCN2 VPS9D1 |
Hand grip strength (left) |
1.42 |
21 |
18 |
40.0 |
-0.61 |
2.4e-03 |
AC034220.3 ACP2 ARHGAP27 C1QTNF4 CASKIN1 CCDC92 CENPO CORT CTD-2033A16.3 DCAF16 EDEM3 FER MTCH2 PDLIM4 RP11-214K3.24 RP11-347C12.2 RP11-380L11.3 RP11-73O6.3 RP13-39P12.3 SLC22A4 SLC9A3R2 |
Number of treatments/medications taken |
1.37 |
5 |
3 |
6.7 |
0.39 |
5.2e-01 |
DCAF16 DCLRE1B MST1R PTPN22 SH2B3 |
Sensitivity / hurt feelings |
1.08 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
ARHGAP27 PTCH1 |
Frequency of depressed mood in last 2 weeks |
1.12 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP5-1115A15.1 |
Relative age of first facial hair |
1.12 |
6 |
2 |
4.4 |
0.01 |
9.8e-01 |
ARHGAP27 C6orf106 FLJ43663 FNDC4 NRBF2 PRUNE |
Systolic blood pressure, automated reading |
1.42 |
25 |
13 |
28.9 |
0.12 |
5.3e-01 |
ARHGAP27 ARHGAP42 ARVCF ATF1 CDK6 DCAF16 DNAJC12 ENO1 FER FES GATAD1 HELLS KRIT1 NFKBIA RP5-1029K10.2 RP5-1115A15.1 RPS6KB1 SH2B3 SLC39A13 SLC5A11 SLC9A3R2 TIE1 TMEM116 UBXN2A YWHAE |
Angina |
1.27 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CDKN2B FES |
Medication: Metformin |
1.42 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
AC074117.10 FNDC4 |
Pack years adult smoking proportion |
1.13 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
XRCC3 |
Impedance of leg (right) |
1.36 |
44 |
32 |
71.1 |
0.31 |
1.8e-02 |
AC074117.10 ADCK3 ATF1 BCKDK C6orf106 CERS5 CLUAP1 EBPL EHD4 FES FLJ33630 FNDC4 GCKR GRLF1 HAUS8 HEATR3 HELLS HMG20A HOXC6 KAT2B LARP4 LIMK2 MARS2 MITF MLXIPL MRPS21 MST1R ORAOV1 PAM PAQR8 PIPSL RIN3 RP11-347C12.1 RP11-347C12.2 RP11-429P3.3 RP11-73O6.3 RP5-1029K10.2 RPS10 RPS6KB1 SMG6 SREBF1 TBX6 XRCC3 ZNF292 |
Leg fat-free mass (left) |
1.62 |
64 |
53 |
117.8 |
-0.51 |
3.2e-06 |
AC034220.3 AC074117.10 ADO AK9 ATP13A1 BCKDK C18orf8 C6orf106 CASKIN1 CCDC126 CDK6 CENPW CTC-498M16.2 CUX2 DCAF16 EBPL EIF2S2 FLJ33630 FNDC3B FNDC4 G6PC2 GATAD1 GCKR GNA12 GRLF1 HELLS HOMEZ HSD17B3 IPPK KIAA1614 KRIT1 MAP3K3 MARK3 MAX MLXIPL MRPS21 MST1R NFKBIA NOSTRIN NPIPB6 ORAOV1 PARP12 PDLIM4 PPP2R3C PPTC7 PTCH1 RFT1 RIN3 RP11-347C12.1 RP11-347C12.2 RP11-73O6.3 RP13-39P12.3 RPS10 SEPT12 SETD1A SLC22A4 SLC5A11 SLC9A3R2 SMG6 TBX6 TRAF3 TTC19 UQCRQ ZNF76 |
Trunk fat percentage |
1.50 |
44 |
34 |
75.6 |
0.07 |
6.5e-01 |
ABO ACP2 ATF1 BCKDK C14orf142 C18orf8 C1QTNF4 C4orf44 C6orf106 CASKIN1 CCDC92 CENPO CENPW CTD-2033A16.3 EDEM3 EIF2S2 FNBP4 GFPT1 GNA12 GRK4 HOXC6 LARP4 MINK1 MST1R MTCH2 NPIPB6 PDE4B RABEP1 RIN3 RP11-138A9.1 RP11-214K3.24 RP11-347C12.2 RP11-380L11.3 RP5-1115A15.1 RPS10 SETD1A SLC5A11 SLC9A3R2 SPTBN1 TRAF3 TUBG2 UBASH3B ZHX3 ZNF12 |
Hand grip strength (right) |
1.36 |
21 |
14 |
31.1 |
-0.58 |
3.6e-03 |
AC034220.3 ARHGAP27 C1QTNF4 CASKIN1 CCDC92 CENPO CORT CTD-2033A16.3 DCAF16 EDEM3 MAN2C1 MAX MTCH2 PDLIM4 RFT1 RP11-214K3.24 RP11-380L11.3 RP11-73O6.3 RP13-39P12.3 SLC22A4 SLC9A3R2 |
Current tobacco smoking |
1.34 |
6 |
2 |
4.4 |
0.59 |
2.2e-01 |
AATK MAPKAPK5 PPP1R13B RP11-73M18.8 SLC5A11 XRCC3 |
Average weekly fortified wine intake |
0.94 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RFT1 |
Maternal smoking around birth |
1.21 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
KLC1 SLC5A11 ZKSCAN5 |
Fed-up feelings |
0.99 |
4 |
4 |
8.9 |
-0.98 |
2.1e-02 |
AC009228.1 ARHGAP27 MST1R SH2B3 |
Relative age voice broke |
1.00 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ARHGAP27 |
Taking other prescription medications |
1.48 |
4 |
4 |
8.9 |
0.08 |
9.0e-01 |
DCLRE1B MST1R PTPN22 SH2B3 |
Age when periods started (menarche) |
1.25 |
16 |
9 |
20.0 |
-0.18 |
5.0e-01 |
AC074117.10 C1QTNF4 CENPO CENPW CTD-2033A16.3 FNBP4 HMG20A LEPR LEPROT MTCH2 NFKBIA NRBF2 NUCB2 SNX1 STXBP5 TIPARP |
Heel bone mineral density (BMD) T-score, automated (left) |
1.44 |
20 |
12 |
26.7 |
-0.32 |
1.2e-01 |
C11orf10 CCDC92 CMIP CYB5D1 EBPL FADS1 FTH1P20 GATAD1 KLC1 MPP2 MS4A2 RNF212 RP11-380L11.3 RP5-1115A15.1 SMG6 SPTBN1 SUPT3H TIPARP TPCN2 ZHX3 |
High blood pressure |
1.55 |
28 |
17 |
37.8 |
0.53 |
2.3e-03 |
ABO ACP2 ADAM1A ARHGAP42 BCKDK CMIP CYB5D1 DCAF16 FBF1 FES FTH1P20 HAUS8 HOXC6 LA16c-358B7.3 MOBP NEK10 NRBF2 NUCB2 PDLIM4 RP11-138A9.1 RP5-1115A15.1 SETD1A SH2B3 SLC39A13 SLC5A11 SMG6 TMEM116 UBE2E3 |
Hayfever, allergic rhinitis or eczema |
1.90 |
34 |
26 |
57.8 |
0.25 |
1.1e-01 |
AC004041.2 AC074117.10 ADAM1A AHI1 AHSA2 ARHGAP15 BACH2 C17orf46 C6orf106 CCDC116 DEXI EIF1AD ENO1 GSDMB IQGAP1 MED24 MSL1 NDFIP1 PDLIM4 POLI RGS14 RP11-373D23.3 RP3-388E23.2 RP5-1115A15.1 RTF1 SLC22A4 SREBF1 STARD3 STMN3 THRA TRAF1 TRAF3 TUBG2 UQCRQ |
Medication: Atenolol |
1.23 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
FES SH2B3 |
Medication: Levothyroxine sodium |
2.02 |
19 |
15 |
33.3 |
0.40 |
4.8e-02 |
AC009506.1 ADAM1A BACH2 C11orf10 DCLRE1B DOK6 FADS1 FADS2 MAPKAPK5 OLFML3 PHTF1 PPP1R32 PTPN22 RAB2A RP3-388E23.2 SH2B3 TCTN1 TMEM116 VPS29 |
Sitting height |
1.72 |
98 |
78 |
173.3 |
-0.56 |
3.7e-11 |
AC009228.1 AC034220.3 AC074117.10 ACP2 AK9 AP3D1 ARHGAP27 ATF1 BRD3 C11orf10 C1QTNF4 C6orf106 CALCRL CASKIN1 CCDC116 CCDC126 CDK2AP1 CDK6 CDKN1B CENPO CENPW CERS5 CNIH4 CORO7 CTD-2033A16.3 DCAF16 DENND1A DHRS13 EBPL EIF2S2 EVI5 FADS1 FLNB FNBP4 FNDC3B FNDC4 G6PC2 GALNT1 GATAD1 GCKR GNA12 GRK4 GSK3A HELLS HSD17B3 IPPK ITSN2 KIAA1614 KRIT1 LETMD1 LMNA LOC375190 LYZ MAN2C1 MAP3K3 MARK3 MAX MLXIPL MTCH2 MYBL2 NEK10 NOSTRIN PARP12 PCDHB16 PDLIM4 PFN4 PNKD PRTFDC1 PTCH1 REST RFT1 RP11-380L11.3 RP11-73O6.3 RP13-39P12.3 RP5-1029K10.2 RPS10 SAAL1 SDCCAG3 SLC22A4 SLC23A3 SLC39A13 SLC9A3R2 SPPL2A SSH2 ST3GAL6-AS1 SUPT3H TIPARP TTC19 TULP4 UBE4B UBXN2A UQCRQ USP37 WAC-AS1 WNT3 ZKSCAN5 ZNF12 ZNF76 |
High blood pressure (mother) |
1.20 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
FES |
Body mass index (BMI) |
1.39 |
51 |
38 |
84.4 |
0.30 |
2.3e-02 |
ACP2 ANTXR2 BCKDK BTBD7 C14orf142 C18orf8 C1QTNF4 C4orf44 C6orf106 CENPO CTC-498M16.2 CTD-2033A16.3 DCAF16 EDEM3 EIF2S2 EVI5 FNBP4 GP1BA GRK4 H2AFV HMG20A ITGAL KAT2B KLC1 MARS2 MINK1 MST1R MTCH2 NOP14 NPIPB6 NRBF2 ORAOV1 PDE4B PFN1 PPTC7 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP5-1115A15.1 RPS10 SETD1A SLC5A11 SLC9A3R2 SMG6 TBX6 TRAF3 TUBG2 UBASH3B XRCC3 ZKSCAN5 |
Impedance of leg (left) |
1.36 |
43 |
35 |
77.8 |
0.30 |
2.2e-02 |
AC074117.10 ADCK3 ATF1 ATP13A1 BCKDK C6orf106 CERS5 CLUAP1 EBPL EHD4 FES FLJ33630 FNDC4 GCKR GRLF1 HAUS8 HEATR3 HELLS HMG20A HOXC6 KAT2B LARP4 LIMK2 MARS2 MITF MLXIPL MRPS21 MST1R ORAOV1 PAM PIPSL RIN3 RP11-347C12.1 RP11-347C12.2 RP11-429P3.3 RP11-73O6.3 RP5-1029K10.2 RPS6KB1 SMG6 SREBF1 TSHR XRCC3 ZNF292 |
Leg predicted mass (left) |
1.61 |
65 |
53 |
117.8 |
-0.50 |
2.9e-06 |
AC034220.3 AC074117.10 ADO AK9 ATP13A1 BCKDK C18orf8 C6orf106 CASKIN1 CBX7 CCDC126 CDK6 CENPW CTC-498M16.2 CUX2 DCAF16 EBPL EIF2S2 FLJ33630 FNDC3B FNDC4 G6PC2 GATAD1 GCKR GNA12 GRLF1 HELLS HOMEZ HSD17B3 IPPK KIAA1614 KRIT1 MAP3K3 MARK3 MAX MLXIPL MRPS21 MST1R NFKBIA NOSTRIN NPIPB6 ORAOV1 PARP12 PDLIM4 PPP2R3C PPTC7 PTCH1 RFT1 RIN3 RP11-347C12.1 RP11-347C12.2 RP11-73O6.3 RP13-39P12.3 RPS10 SEPT12 SETD1A SLC22A4 SLC5A11 SLC9A3R2 SMG6 TBX6 TRAF3 TTC19 UQCRQ ZNF76 |
Trunk fat mass |
1.40 |
43 |
31 |
68.9 |
0.04 |
7.8e-01 |
ACP2 ATP13A1 BCKDK C14orf142 C18orf8 C1QTNF4 C6orf106 CASKIN1 CCDC92 CDK6 CENPO CTC-498M16.2 CTD-2033A16.3 EDEM3 EIF2S2 FLJ13197 GFPT1 GNA12 GP1BA LARP4 MST1R MTCH2 NPIPB6 PDE4B PPTC7 PTPMT1 RABEP1 RP11-138A9.1 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP11-73O6.3 RP5-1115A15.1 RPS10 SETD1A SLC5A11 SLC9A3R2 TBX6 TRAF3 TUBG2 UBASH3B ZHX3 |
Waist circumference |
1.38 |
42 |
25 |
55.6 |
0.13 |
4.1e-01 |
ACP2 BCKDK BTBD7 C14orf142 C18orf8 C1QTNF4 C4orf44 C6orf106 CALCRL CASKIN1 CDK6 CENPO CMIP CTC-498M16.2 CTD-2033A16.3 EDEM3 EIF2S2 GNA12 GRK4 HOXC6 MEG3 MST1R MTCH2 NPIPB6 PAX8 PDE4B PLA2R1 PTPMT1 RP11-347C12.1 RP11-347C12.2 SETD1A SLC5A11 SLC9A3R2 SMG6 TBX6 TIPARP TRAF3 TUBG2 UBASH3B XRCC3 ZKSCAN5 ZNF785 |
Number of incorrect matches in round |
1.05 |
5 |
2 |
4.4 |
0.76 |
1.4e-01 |
BCKDK RP11-347C12.1 RP11-347C12.2 SETD1A TULP4 |
Past tobacco smoking |
1.15 |
5 |
0 |
0.0 |
-0.67 |
2.2e-01 |
C18orf8 CTD-2033A16.3 PDE4B PHTF1 SH2B3 |
Alcohol usually taken with meals |
1.07 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
NRBF2 RABGAP1L RMI1 |
Nervous feelings |
1.12 |
6 |
2 |
4.4 |
0.31 |
5.5e-01 |
ARHGAP27 CENPW CTC-498M16.2 FNBP4 FRAT2 SETD1A |
Frequency of tenseness / restlessness in last 2 weeks |
1.08 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
AATK ARHGAP27 WNT3 |
Hearing difficulty/problems with background noise |
1.16 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
KLC1 XRCC3 |
Had menopause |
1.09 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
AC074117.10 NRBP1 |
Forced vital capacity (FVC) |
1.63 |
53 |
40 |
88.9 |
-0.44 |
3.0e-04 |
ACP2 ADAMTSL4 AHI1 AK9 ARHGAP27 BCKDK C1QTNF4 C6orf106 CACFD1 CCDC126 CDK5RAP3 CDK6 CENPO CENPW CLUAP1 CTB-36H16.2 CTD-2033A16.3 DCAF16 EBPL FER FLJ33630 FLNB FNBP4 FNDC3B GATAD1 GNA12 GSK3A HSD17B3 KIAA1614 MAN2C1 MAP3K3 MTCH2 PCDHB16 PHLDB1 PINLYP PNKD PTCH1 REST RIN3 RP11-73O6.3 RP13-39P12.3 RP3-388E23.2 SETD1A SSH2 STMN3 SURF6 SV2A TULP4 UBE4B UBXN2A WAC-AS1 WNT3 ZNF76 |
Heel bone mineral density (BMD) T-score, automated (right) |
1.48 |
24 |
12 |
26.7 |
-0.34 |
7.4e-02 |
ACP2 C11orf10 CCDC92 CDK6 CYB5D1 ENO1 FADS1 FADS2 FTH1P20 GATAD1 KLC1 MS4A2 RNF212 RP11-380L11.3 RP5-1115A15.1 SCAP SMG6 SPTBN1 SUPT3H TIPARP TPCN2 TTLL12 ZHX3 ZNF76 |
Qualifications: None of the above |
1.10 |
6 |
4 |
8.9 |
0.62 |
1.9e-01 |
CKM CTC-498M16.2 GRK4 MST1R NRBF2 SIDT2 |
Financial difficulties in last 2 years |
1.15 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
XRCC3 |
Mouth/teeth dental problems |
1.19 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
KLC1 |
Heart attack |
1.36 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
FES |
Allergy |
2.09 |
33 |
25 |
55.6 |
-0.30 |
4.8e-02 |
ABO AC004041.2 AHI1 BACH2 C17orf37 C17orf46 DEXI ENO1 FADS1 FADS2 GSDMB IL1RN IQGAP1 MED24 MSL1 NDFIP1 PDLIM4 PGAP3 POLI RBBP8 RGS14 RIN3 RP3-388E23.2 RP5-1029K10.2 RP5-1115A15.1 RTF1 SLC22A4 STARD3 STMN3 THRA TRAF1 TUBG2 UQCRQ |
Diabetes (self-reported) |
1.48 |
5 |
2 |
4.4 |
-0.61 |
2.7e-01 |
AC074117.10 FLJ33630 FNDC4 MST1R SNX17 |
Medication: Simvastatin |
1.37 |
4 |
3 |
6.7 |
-0.44 |
5.6e-01 |
ABO FES FNDC4 PVRL2 |
Fluid intelligence score |
1.21 |
8 |
4 |
8.9 |
-0.72 |
4.2e-02 |
C1QTNF4 DCAF16 FNBP4 FRAT2 MST1R MTCH2 NPIPB6 RP11-73M18.8 |
Illnesses of siblings |
1.28 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
BCKDK C4orf44 SH2B3 |
Neuroticism score |
1.09 |
8 |
5 |
11.1 |
0.08 |
8.5e-01 |
AATK ARHGAP27 FNBP4 MTCH2 PTCH1 RP5-1115A15.1 SETD1A WNT3 |
Weight |
1.46 |
49 |
36 |
80.0 |
-0.27 |
4.5e-02 |
AC074117.10 BCKDK BTBD7 C14orf142 C18orf8 C1QTNF4 C6orf106 CASKIN1 CDK6 CENPW CTC-498M16.2 CUX2 DCAF16 EBPL EIF2S2 FNDC4 G6PC2 GATAD1 GCKR GFPT1 GNA12 ITGAL KRIT1 MEG3 MLXIPL MST1R NOSTRIN NPIPB6 ORAOV1 PAX8 PDE4B PDLIM4 PPTC7 PTPMT1 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP11-73O6.3 RPS10 SETD1A SLC5A11 SLC9A3R2 SMG6 TBX6 TRAF3 TUBG2 UBASH3B ZNF76 ZNF785 |
Impedance of arm (right) |
1.32 |
47 |
32 |
71.1 |
-0.03 |
8.0e-01 |
ABO AC074117.10 ADCK3 ARHGAP27 ATF1 BCKDK CCDC92 CENPW CERS5 CORT CTC-498M16.2 EIF2S2 FAM117B FBLN7 FNDC4 GCKR GRLF1 HAUS8 HELLS HMG20A HOXC6 KAT2B LARP4 LIMK2 MED24 MLXIPL MST1R NRBF2 PIPSL PPTC7 PRUNE RAB7A RIN3 RMI1 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP11-554A11.9 RP11-73O6.3 RP11-864G5.3 RP5-1029K10.2 RPS6KB1 SMG6 SNORD89 TIPARP ZNF292 |
Arm fat percentage (right) |
1.54 |
47 |
36 |
80.0 |
0.24 |
7.2e-02 |
ABO ACP2 ANTXR2 BCKDK C14orf142 C18orf8 C1QTNF4 C4orf44 C6orf106 CCDC92 CENPO CENPW CTC-498M16.2 CTD-2033A16.3 DCAF16 EDEM3 EIF2S2 FNBP4 GFPT1 GP1BA GRK4 ITGAL KLC1 LRRC25 MARS2 MINK1 MST1R MTCH2 NOP14 NPIPB6 PDE4B PFN1 RP11-138A9.1 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP5-1115A15.1 RSPH10B2 SETD1A SLC5A11 TRAF3 TUBG2 UBASH3B XRCC3 ZKSCAN5 ZNF12 |
Trunk fat-free mass |
1.94 |
91 |
69 |
153.3 |
-0.43 |
1.8e-06 |
ABO AC034220.3 AC074117.10 ACP2 AK9 C18orf8 C1QTNF4 C6orf106 CASKIN1 CBX7 CCDC126 CCDC92 CDK6 CDKN1B CENPO CENPW CNIH4 CORO7 CTC-498M16.2 CUX2 DCAF16 DZIP1 EBPL EIF2S2 ETHE1 FLJ33630 FNBP4 FNDC3B FNDC4 G6PC2 GALNT1 GATAD1 GCKR GNA12 GRLF1 HELLS HOMEZ HSD17B3 IMP3 IPPK KANSL2 KIAA1614 KRIT1 MAN2C1 MAP3K3 MARK3 MAX MLXIPL MRPS21 MST1R MTCH2 NDST1 NFKBIA NOSTRIN ORAOV1 PARP12 PDLIM4 PHLDB3 PINLYP PIPSL PNKD PPP2R3C PPTC7 PTCH1 REST RFT1 RIN3 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-373D23.3 RP11-380L11.3 RP11-73M18.8 RP11-73O6.3 RP13-39P12.3 RPS10 SDCCAG3 SH2B3 SLC22A4 SLC39A13 SLC9A3R2 SMG6 SNORD124 TBX6 TRAF3 UBE4B UBXN2A USP37 VPS9D1 WAC-AS1 ZNF76 |
Hip circumference |
1.54 |
48 |
32 |
71.1 |
-0.23 |
9.9e-02 |
ACP2 ATP13A1 BCKDK BTBD7 C14orf142 C18orf8 C1QTNF4 C6orf106 CASKIN1 CCDC92 CDK6 CENPO CORO7 CTC-498M16.2 CTD-2033A16.3 EBPL EIF2S2 FNDC4 GATAD1 GNA12 GP1BA ITGAL MEG3 MINK1 MLXIPL MST1R MTCH2 NPIPB6 ORAOV1 PDE4B PPTC7 RP11-138A9.1 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP11-73O6.3 RPS10 SETD1A SH2B3 SLC9A3R2 SREBF1 TBX6 TPCN2 TRAF3 UBASH3B VPS29 ZNF785 |
Alcohol intake versus 10 years previously |
1.04 |
4 |
3 |
6.7 |
0.99 |
9.7e-03 |
AC074117.10 FNDC4 GCKR MST1R |
Father's age at death |
1.40 |
3 |
2 |
4.4 |
-0.27 |
7.3e-01 |
ABO FES SH2B3 |
Worrier / anxious feelings |
0.98 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
ARHGAP27 PTCH1 SETD1A |
Frequency of tiredness / lethargy in last 2 weeks |
1.11 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
AATK C4orf44 RP5-1115A15.1 |
Hair/balding pattern: Pattern 3 |
1.02 |
4 |
4 |
8.9 |
0.75 |
2.5e-01 |
ARHGAP27 CENPW WNT3 ZHX3 |
Number of live births |
1.10 |
4 |
2 |
4.4 |
0.98 |
1.7e-02 |
C11orf10 FADS1 FADS2 PPP1R32 |
Forced expiratory volume in 1-second (FEV1) |
1.59 |
48 |
28 |
62.2 |
-0.49 |
2.1e-04 |
ABO ACP2 ADAMTSL4 AK9 ARHGAP27 BCKDK C14orf142 C1QTNF4 C6orf106 CACFD1 CCDC126 CCDC69 CD46 CDK6 CENPO CENPW CLUAP1 CTB-36H16.2 CTD-2033A16.3 DCAF16 EBPL FBXO38 FER FLNB FNDC3B GRK4 GSK3A HSD17B3 KIAA1614 MAN2C1 MAP3K3 MTCH2 NFKBIA NOP14 PTCH1 REST RIN3 RP11-73O6.3 RP13-39P12.3 RP3-388E23.2 SETD1A STMN3 SV2A TULP4 UBXN2A WAC-AS1 WNT3 ZNF76 |
Pulse rate |
1.20 |
7 |
5 |
11.1 |
0.04 |
9.3e-01 |
AC074117.10 C11orf10 FADS1 FADS2 FNDC4 GCKR TCTEX1D1 |
Qualifications: A levels/AS levels or equivalent |
0.98 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
MST1R NRBF2 |
Mouth/teeth dental problems: Dentures |
1.28 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
MST1R RPS6KB1 |
Asthma |
2.13 |
26 |
22 |
48.9 |
0.53 |
8.4e-04 |
AC004041.2 AHI1 BACH2 C11orf10 DEXI ENO1 FADS1 FADS2 GSDMB MED24 MSL1 NDFIP1 PDLIM4 PGAP3 PPP1R32 RIN3 RP1-102E24.8 RP3-388E23.2 RP5-1029K10.2 RP5-1115A15.1 RTF1 SLC22A4 STARD3 THRA UQCRQ ZNF76 |
Medication: Ibuprofen (e.g. Nurofen) |
1.17 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ARHGAP27 |
Medication: Cholesterol lowering |
1.41 |
8 |
6 |
13.3 |
0.23 |
5.8e-01 |
ABO AC074117.10 ATP13A1 FES FNDC4 GCKR PVRL2 SIDT2 |
Depression (self-reported) |
1.05 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP5-1115A15.1 |
Illnesses of mother |
1.18 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
FES |
Forced expiratory volume in 1-second (FEV1), Best measure |
1.59 |
34 |
21 |
46.7 |
-0.42 |
8.4e-03 |
ABO ACP2 AK9 ARHGAP27 BCKDK C1QTNF4 C5orf34 C6orf106 CACFD1 CENPW CLUAP1 CTB-36H16.2 CTD-2033A16.3 DCAF16 EBPL FBXO38 FER FLNB FNDC3B GSK3A HSD17B3 KIAA1614 MTCH2 NOP14 PTCH1 REST RIN3 RP11-73O6.3 RP13-39P12.3 SETD1A TULP4 UBXN2A WNT3 ZNF76 |
Pulse wave Arterial Stiffness index |
1.24 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ADAM1A |
Impedance of arm (left) |
1.33 |
44 |
29 |
64.4 |
-0.02 |
9.0e-01 |
ABO AC074117.10 ARHGAP27 ATF1 BCKDK CCDC92 CENPW CERS5 CORT CTC-498M16.2 EIF2S2 FAM117B FBLN7 FER FNDC4 GCKR GNA12 GRLF1 HAUS8 HEATR3 HELLS HMG20A HOXC6 KAT2B LIMK2 MLXIPL MST1R NRBF2 PIPSL PPP2R3C PRUNE RCN2 RIN3 RMI1 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP11-554A11.9 RP11-73O6.3 RP5-1029K10.2 SH2B3 SMG6 SNORD89 |
Arm fat mass (right) |
1.39 |
45 |
31 |
68.9 |
0.13 |
4.1e-01 |
ACP2 BCKDK C14orf142 C18orf8 C1QTNF4 C4orf44 C6orf106 CASKIN1 CDK6 CENPO CTC-498M16.2 CTD-2033A16.3 EDEM3 EIF2S2 GFPT1 GNA12 GP1BA GRK4 ITGAL MARS2 MEG3 MINK1 MST1R MTCH2 NPIPB6 ORAOV1 PDE4B PFN1 PPTC7 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP11-73O6.3 RP5-1115A15.1 RPS10 SETD1A SLC5A11 SLC9A3R2 TBX6 TRAF3 TUBG2 UBASH3B XRCC3 ZKSCAN5 |
Trunk predicted mass |
1.93 |
89 |
69 |
153.3 |
-0.43 |
1.9e-06 |
ABO AC034220.3 AC074117.10 ACP2 AK9 C18orf8 C6orf106 CASKIN1 CBX7 CCDC126 CCDC92 CDK6 CDKN1B CENPO CENPW CNIH4 CORO7 CTC-498M16.2 CUX2 DCAF16 DZIP1 EBPL EIF2S2 ETHE1 FLJ33630 FNBP4 FNDC3B FNDC4 G6PC2 GALNT1 GATAD1 GCKR GNA12 GRLF1 HELLS HOMEZ HSD17B3 IMP3 IPPK KANSL2 KIAA1614 KRIT1 MAN2C1 MAP3K3 MARK3 MAX MLXIPL MRPS21 MST1R MTCH2 NDST1 NFKBIA NOSTRIN ORAOV1 PARP12 PDLIM4 PHLDB3 PINLYP PIPSL PNKD PPP2R3C PPTC7 PTCH1 REST RFT1 RIN3 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-373D23.3 RP11-380L11.3 RP11-73M18.8 RP11-73O6.3 RP13-39P12.3 RPS10 SDCCAG3 SH2B3 SLC22A4 SLC39A13 SLC9A3R2 SMG6 SNORD124 TBX6 UBE4B UBXN2A USP37 VPS9D1 WAC-AS1 ZNF76 |
Standing height |
1.86 |
130 |
111 |
246.7 |
-0.44 |
1.1e-08 |
AC004041.2 AC034220.3 AC074117.10 ACP2 ADO AK9 ANKRD17 AP3D1 ARHGAP27 ASPRV1 ATF1 ATP13A1 BRD3 C11orf10 C18orf8 C1QTNF4 C6orf106 CACNA1H CASKIN1 CBX7 CCDC126 CCT6A CDK2AP1 CDK6 CDKN1B CENPO CENPW CERS5 CGREF1 CNIH4 CORO7 CTD-2033A16.3 CUX2 DCAF16 DLEU7 EBPL EDEM3 ETHE1 ETS1 EVI5 FADS1 FADS2 FER FLJ13197 FNBP4 FNDC3B FNDC4 G6PC2 GALNT1 GATAD1 GCKR GNA12 GRK4 GSK3A HDAC3 HMG20A HOMEZ HSD17B3 IMP3 IPPK KIAA1614 KLC1 KRIT1 LETMD1 LMNA LYZ MAN2C1 MAP3K3 MARK3 MAX MIER1 MSL1 MTCH2 NFKBIA NOP14 NOSTRIN NRBF2 NRBP1 PARP12 PCDHB16 PDLIM4 PHLDB3 PINLYP PNKD PTCH1 RBBP8 RCN2 REST RFT1 RGS14 RIC8B RMI1 RP11-214K3.24 RP11-380L11.3 RP11-73M18.8 RP11-73O6.3 RP13-39P12.3 RP5-1029K10.2 RP5-1115A15.1 RPS10 SAAL1 SDCCAG3 SEC1 SEPT12 SH2B3 SLC22A4 SLC23A3 SLC39A13 SLC9A3R2 SNORD124 SPC25 SPPL2A SSH2 SUPT3H TBC1D14 TMEM181 TNKS2 TPCN2 TRPM7 TULP4 UBE4B UBXN2A UQCRQ USP37 VPS9D1 WAC-AS1 XRCC3 ZKSCAN5 ZNF575 ZNF76 |
Tense / 'highly strung' |
1.13 |
4 |
2 |
4.4 |
0.60 |
2.9e-01 |
AATK RP11-78O7.2 RP5-1115A15.1 SETD1A |
Hair/balding pattern: Pattern 4 |
1.16 |
15 |
9 |
20.0 |
0.25 |
3.2e-01 |
ARHGAP27 ATF1 C11orf10 CENPW CERS5 CITED4 CTB-36H16.2 FADS1 KAT2B LARP4 POLI RP13-39P12.3 RP5-1115A15.1 WNT3 ZHX3 |
Birth weight of first child |
1.55 |
7 |
5 |
11.1 |
-0.92 |
3.9e-03 |
DCAF16 FES LPAR1 RP11-864G5.3 SH2B3 TIPARP ZKSCAN5 |
Peak expiratory flow (PEF) |
1.29 |
10 |
5 |
11.1 |
0.34 |
2.6e-01 |
ABO ARHGAP27 BOD1 CACFD1 DCAF16 EBPL FBXO38 SLC9A3R2 TULP4 ZNF76 |
Ever highly irritable/argumentative for 2 days |
1.04 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MST1R |
Qualifications: O levels/GCSEs or equivalent |
1.02 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RPS6KB1 |
Blood clot in the leg (DVT) |
2.09 |
4 |
3 |
6.7 |
-0.75 |
8.4e-02 |
ABO CACFD1 NUDT14 SARDH |
Medication: Paracetamol |
1.06 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ARHGAP27 |
Headache pain in last month |
1.24 |
5 |
2 |
4.4 |
-0.44 |
4.6e-01 |
AC005702.4 ARHGAP27 MRPS21 RP11-54A4.2 WNT3 |
Medication for cholesterol, blood pressure or diabetes |
1.30 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
FES NEK10 SH2B3 |
Gout (self-reported) |
1.40 |
6 |
5 |
11.1 |
0.91 |
1.2e-02 |
AC074117.10 FNDC4 GCKR MLXIPL NRBP1 SH2B3 |
Hypothyroidism/myxoedema (self-reported) |
2.28 |
26 |
15 |
33.3 |
0.32 |
6.5e-02 |
AC009506.1 ACAP1 ADAM1A AHI1 BACH2 C11orf10 CHD7 DCLRE1B DOK6 FADS1 FADS2 MAPKAPK5 OLFML3 PHTF1 PKN3 PPP1R32 PTPN22 RAB2A RP11-326C3.11 RP3-388E23.2 RP3-462E2.3 RP5-1115A15.1 SH2B3 TCTN1 TMEM116 VPS29 |
Medication: Amlodipine |
1.28 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
FES |
Medication: Ventolin 100micrograms inhaler |
1.33 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
GSDMB STARD3 |
Birth weight |
1.71 |
20 |
14 |
31.1 |
-0.71 |
3.2e-04 |
ACAP1 ADAM1A CCDC126 CENPW DCAF16 FBLN7 FES GNA12 MIER1 MTCH2 ORAOV1 PIPSL PLA2R1 PTCH1 RFT1 RP11-73O6.3 RP11-864G5.3 SH2B3 SLC45A4 TIPARP |
High blood pressure (siblings) |
1.17 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
BCKDK FES SLC39A13 |
Forced vital capacity (FVC), Best measure |
1.63 |
50 |
34 |
75.6 |
-0.51 |
4.2e-05 |
ACP2 AHI1 ARHGAP27 BCKDK C1QTNF4 CACFD1 CCDC126 CDK5RAP3 CDK6 CENPO CENPW CLUAP1 CTB-36H16.2 CTD-2033A16.3 DCAF16 EBPL FER FLJ33630 FNBP4 FNDC3B GATAD1 GNA12 GRK4 GSK3A HMG20A HSD17B3 KIAA1614 MAN2C1 MAP3K3 MST1R MTCH2 NOP14 PCDHB16 PTCH1 RCN2 REST RIN3 RP11-73O6.3 RP13-39P12.3 RP3-388E23.2 SETD1A SETDB2 SSH2 STMN3 TULP4 UBE4B UBXN2A WAC-AS1 WNT3 ZNF76 |
Body fat percentage |
1.58 |
49 |
33 |
73.3 |
0.32 |
1.6e-02 |
ACP2 ANTXR2 BCKDK C14orf142 C18orf8 C1QTNF4 C4orf44 C6orf106 CCDC92 CENPO CENPW CTC-498M16.2 CTD-2033A16.3 EDEM3 EIF2S2 FLJ33630 FNBP4 GFPT1 GP1BA GRK4 HELLS HOXC6 LARP4 MINK1 MST1R MTCH2 NOP14 NPIPB6 PDE4B PFN1 PMS2CL RIN3 RP11-138A9.1 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP5-1115A15.1 RSPH10B2 SETD1A SLC5A11 SLC9A3R2 TRAF3 TUBG2 UBASH3B WWP1 ZHX3 ZKSCAN5 ZNF12 |
Leg fat percentage (right) |
1.67 |
49 |
35 |
77.8 |
0.42 |
1.7e-03 |
AC009228.1 ACP2 ANTXR2 BCKDK C14orf142 C18orf8 C1QTNF4 C4orf44 C6orf106 CALCRL CCDC92 CENPO CENPW CTC-498M16.2 CTD-2033A16.3 DCAF16 EDEM3 EIF2S2 FLJ33630 FNBP4 GRK4 H2AFV HELLS HSD17B3 MINK1 MOBP MST1R MTCH2 NPIPB6 PDE4B RIN3 RP11-138A9.1 RP11-214K3.24 RP11-347C12.2 RP11-380L11.3 RP5-1115A15.1 RSPH10B2 SETD1A SIDT2 SLC39A13 SLC5A11 SLC9A3R2 SSH2 TRAF3 UBASH3B WWP1 ZHX3 ZKSCAN5 ZNF12 |
Arm fat-free mass (right) |
1.78 |
71 |
52 |
115.6 |
-0.42 |
3.3e-05 |
ABO AC034220.3 AC074117.10 ADAM1A AK9 BCKDK C18orf8 C6orf106 CASKIN1 CBX7 CCDC126 CCDC92 CDK6 CENPW CNIH4 CORO7 CTC-498M16.2 CUX2 DCAF16 EBPL EIF2S2 FNDC3B FNDC4 G6PC2 GATAD1 GCKR GNA12 GRLF1 HELLS HSD17B3 IPPK KIAA1614 KRIT1 MAP3K3 MARK3 MAX MEG3 MLXIPL MRPS21 MST1R NFKBIA NOSTRIN PARP12 PDLIM4 PIPSL PNKD PPP2R3C PPTC7 PTCH1 RFT1 RIN3 RP11-347C12.1 RP11-347C12.2 RP11-373D23.3 RP11-380L11.3 RP11-73M18.8 RP11-73O6.3 RP13-39P12.3 RPS10 SETD1A SH2B3 SLC22A4 SLC39A13 SLC5A11 SLC9A3R2 SMG6 TRAF3 UBXN2A VPS29 WAC-AS1 ZNF76 |
Comparative body size at age 10 |
1.45 |
20 |
12 |
26.7 |
-0.01 |
9.5e-01 |
ACP2 AP3D1 BCKDK C1QTNF4 CALCRL CENPO CERS5 CTC-498M16.2 FNBP4 ITGAL LEPR LEPROT MTCH2 ORAOV1 PLA2R1 RP11-347C12.1 RP11-347C12.2 SETD1A TBX6 ZNF785 |
Seen a psychiatrist for nerves, anxiety, tension or depression |
1.24 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
RP11-73M18.8 |
Wheeze or whistling in the chest in last year |
1.52 |
11 |
5 |
11.1 |
0.65 |
2.1e-02 |
BTBD7 DEXI GSDMB HSD17B3 MED24 MSL1 MST1R PLA2R1 RP11-347C12.2 STARD3 THRA |
Age at first live birth |
1.14 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
C4orf44 MST1R |
Pulse wave peak to peak time |
1.26 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ADAM1A |
Shortness of breath walking on level ground |
1.10 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
C18orf8 |
Qualifications: College or University degree |
1.11 |
16 |
13 |
28.9 |
-0.56 |
1.2e-02 |
ARHGAP27 C18orf8 C4orf44 CACNA1H CKM CLUAP1 CTC-498M16.2 DCAF16 GRK4 MAP3K3 MST1R NOP14 NPIPB6 PRUNE RP11-73M18.8 RP11-864G5.3 |
Medication for pain relief, constipation, heartburn |
1.12 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ARHGAP27 NRBP1 |
Medication: Blood pressure |
1.29 |
7 |
4 |
8.9 |
0.83 |
2.1e-02 |
ADAM1A CMIP DCAF16 FES NEK10 SH2B3 SLC39A13 |
Angina (self-reported) |
1.26 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CDKN2B FES |
Medication: Allopurinol |
1.38 |
4 |
4 |
8.9 |
0.99 |
8.1e-04 |
AC074117.10 FNDC4 GCKR MLXIPL |
Medication: Seretide 50 evohaler |
1.15 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PDLIM4 |
Mean time to correctly identify matches |
1.23 |
5 |
3 |
6.7 |
0.65 |
2.4e-01 |
ITSN2 KLHL18 MIER1 RMI1 SH2B3 |
Whole body fat mass |
1.41 |
44 |
33 |
73.3 |
0.12 |
4.3e-01 |
ACP2 BCKDK C14orf142 C18orf8 C1QTNF4 C4orf44 C6orf106 CASKIN1 CCDC92 CDK6 CENPO CTC-498M16.2 CTD-2033A16.3 EDEM3 EIF2S2 GFPT1 GNA12 GP1BA GRK4 ITGAL MEG3 MST1R MTCH2 NPIPB6 PDE4B PPTC7 PTPMT1 RABEP1 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP11-73O6.3 RP5-1115A15.1 RSPH10B2 SETD1A SLC5A11 SLC9A3R2 TBX6 TRAF3 TUBG2 UBASH3B ZHX3 ZKSCAN5 |
Leg fat mass (right) |
1.46 |
43 |
33 |
73.3 |
0.26 |
8.9e-02 |
ACP2 BCKDK C14orf142 C18orf8 C1QTNF4 C4orf44 C6orf106 CASKIN1 CDK6 CENPO CTC-498M16.2 CTD-2033A16.3 EDEM3 EIF2S2 FLJ33630 GFPT1 GP1BA GRK4 MEG3 MINK1 MST1R MTCH2 NPIPB6 PDE4B PPTC7 RABEP1 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP11-73O6.3 RP5-1115A15.1 RPS10 RSPH10B2 SETD1A SLC5A11 SLC9A3R2 TRAF3 TUBG2 UBASH3B ZHX3 ZKSCAN5 ZNF12 |
Arm predicted mass (right) |
1.77 |
72 |
55 |
122.2 |
-0.43 |
3.3e-05 |
ABO AC034220.3 AC074117.10 ADAM1A AK9 BCKDK C18orf8 C6orf106 CASKIN1 CBX7 CCDC126 CCDC92 CDK6 CENPW CNIH4 CORO7 CTC-498M16.2 CUX2 DCAF16 DZIP1 EBPL EIF2S2 FNDC3B FNDC4 G6PC2 GATAD1 GCKR GNA12 GRLF1 HELLS HSD17B3 IPPK KIAA1614 KRIT1 MAP3K3 MARK3 MAX MEG3 MLXIPL MST1R NFKBIA NOSTRIN PARP12 PDLIM4 PIPSL PNKD PPP2R3C PPTC7 PTCH1 RFT1 RIN3 RP11-347C12.1 RP11-347C12.2 RP11-373D23.3 RP11-380L11.3 RP11-73M18.8 RP11-73O6.3 RP13-39P12.3 RPS10 SETD1A SH2B3 SLC22A4 SLC39A13 SLC5A11 SLC9A3R2 SMG6 TRAF3 UBE4B UBXN2A VPS29 WAC-AS1 ZNF76 |
Pulse rate, automated reading |
1.46 |
32 |
23 |
51.1 |
0.09 |
6.0e-01 |
ABO AC074117.10 BZRAP1 C11orf10 C4orf44 C6orf106 C6orf204 CALCRL CD46 CD55 DNAJC13 FADS1 FADS2 FAM170B FNDC3B FNDC4 GCKR HSD17B3 JMJD6 MLXIPL MST1R PPP1R32 PPTC7 RFT1 RIC8B RP11-864G5.3 SNX17 SREBF1 SSPN TCTEX1D1 ZHX3 ZNF785 |
Alcohol intake frequency. |
1.44 |
19 |
16 |
35.6 |
0.50 |
2.0e-02 |
AC074117.10 ARHGAP27 BCKDK C18orf8 C1QTNF4 C4orf44 CTC-498M16.2 FNDC4 GCKR H2AFV MLXIPL MST1R MTCH2 NPIPB6 NRBP1 RP11-347C12.2 RPS6KB1 SETD1A TUBG2 |
Comparative height size at age 10 |
1.69 |
76 |
60 |
133.3 |
-0.44 |
1.3e-05 |
AC010883.5 AC034220.3 AC074117.10 ACP2 AK9 AP3D1 ARHGAP27 C18orf8 C1QTNF4 C6orf106 CASKIN1 CCDC126 CDK6 CENPO CENPW CNIH4 CUX2 DCAF16 EBPL ETS1 EVI5 FER FNBP4 FNDC3B FNDC4 GALNT1 GATAD1 GCKR GNA12 HOMEZ HSD17B3 IMP3 IPPK KIAA1614 KLC1 KRIT1 LMNA MAP3K3 MARK3 MAX MSL1 MTCH2 NFKBIA NOSTRIN NUCB2 PAX8 PDE4B PDLIM4 PFN4 PNKD PTCH1 RBBP8 RFT1 RIC8B RMI1 RP11-380L11.3 RP11-73M18.8 RP11-73O6.3 RP13-39P12.3 SDCCAG3 SEC1 SEPT12 SH2B3 SLC22A4 SLC23A3 SLC39A13 SLC9A3R2 SNORD124 SUPT3H TAF8 UBXN2A UQCRQ USP37 VPS9D1 XRCC3 ZNF76 |
Suffer from 'nerves' |
1.29 |
4 |
3 |
6.7 |
-0.82 |
1.8e-01 |
AATK C1QTNF4 FNBP4 MTCH2 |
Overall health rating |
1.28 |
8 |
5 |
11.1 |
0.08 |
8.2e-01 |
AATK BCKDK C6orf106 DCLRE1B GRK4 MST1R NOP14 SETD1A |
Chest pain or discomfort |
1.08 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
THRA |
Age at last live birth |
1.05 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
MST1R |
Leg pain on walking |
1.02 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MST1R |
Medication: Aspirin |
1.20 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
FES |
Hypertension (Self-reported) |
1.53 |
28 |
16 |
35.6 |
0.54 |
1.5e-03 |
ABO ACP2 ADAM1A ARHGAP42 BCKDK CMIP CYB5D1 DCAF16 FBF1 FES FTH1P20 HAUS8 HOXC6 LA16c-358B7.3 MOBP NEK10 NRBF2 NUCB2 PDLIM4 RP3-462E2.5 RP5-1115A15.1 RTF1 SETD1A SH2B3 SLC39A13 SLC5A11 SMG6 TMEM116 |
Illnesses of father: Heart disease |
1.33 |
4 |
1 |
2.2 |
-0.02 |
9.7e-01 |
ABO CDKN2B FES MAP1S |
Smoking status: Previous |
1.02 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
C18orf8 SH2B3 |
Forced expiratory volume in 1-second (FEV1), predicted |
1.57 |
17 |
14 |
31.1 |
-0.41 |
6.2e-02 |
C6orf106 CASKIN1 CDK6 CENPW CNIH4 DCAF16 EBPL G6PC2 GNA12 MAP3K3 MTCH2 NOSTRIN PDLIM4 PTCH1 RP11-73O6.3 SDCCAG3 ZNF76 |
Whole body fat-free mass |
1.81 |
82 |
65 |
144.4 |
-0.50 |
1.1e-07 |
AC034220.3 AC074117.10 ADO AK9 BCKDK C18orf8 C6orf106 CASKIN1 CBX7 CCDC126 CCDC92 CDK6 CENPW CNIH4 CORO7 CTC-498M16.2 CUX2 DCAF16 DZIP1 EBPL EIF2S2 FLJ33630 FNDC3B FNDC4 G6PC2 GATAD1 GCKR GNA12 GRLF1 HELLS HOMEZ HSD17B3 IMP3 IPPK KIAA1614 KRIT1 MAN2C1 MAP3K3 MARK3 MAX MEG3 MLXIPL MRPS21 MST1R NFKBIA NOSTRIN NPIPB6 ORAOV1 PARP12 PDLIM4 PIPSL PNKD PPP2R3C PPTC7 PTCH1 RFT1 RIN3 RP11-347C12.1 RP11-347C12.2 RP11-373D23.3 RP11-380L11.3 RP11-73M18.8 RP11-73O6.3 RP13-39P12.3 RPS10 SDCCAG3 SEPT12 SETD1A SH2B3 SLC22A4 SLC39A13 SLC5A11 SLC9A3R2 SMG6 TBX6 TRAF3 UBE4B UBXN2A UQCRQ USP37 WAC-AS1 ZNF76 |
Leg fat-free mass (right) |
1.65 |
67 |
55 |
122.2 |
-0.54 |
2.4e-07 |
AC034220.3 AC074117.10 ADO AK9 ATP13A1 BCKDK C18orf8 C6orf106 CASKIN1 CCDC126 CDK6 CENPW CTC-498M16.2 CUX2 DCAF16 EBPL EHD4 EIF2S2 FLJ33630 FNDC3B FNDC4 G6PC2 GATAD1 GCKR GNA12 GRLF1 HELLS HOMEZ HSD17B3 IPPK KIAA1614 KRIT1 MAP3K3 MARK3 MAX MLXIPL MRPS21 MST1R NFKBIA NOSTRIN NPIPB6 ORAOV1 PARP12 PDLIM4 PIPSL PNKD PPP2R3C PPTC7 PTCH1 RFT1 RIN3 RP11-347C12.1 RP11-347C12.2 RP11-73O6.3 RP13-39P12.3 RPS10 SEPT12 SETD1A SLC22A4 SLC39A13 SLC9A3R2 SMG6 TBX6 TRAF3 TTC19 UQCRQ ZNF76 |
Arm fat percentage (left) |
1.55 |
46 |
34 |
75.6 |
0.23 |
1.0e-01 |
ABO ACP2 ANTXR2 BCKDK C14orf142 C18orf8 C1QTNF4 C4orf44 C6orf106 CCDC92 CENPO CENPW CTC-498M16.2 CTD-2033A16.3 DCAF16 EDEM3 EIF2S2 FNBP4 GFPT1 GP1BA GRK4 ITGAL KLC1 LRRC25 MARS2 MINK1 MST1R MTCH2 NOP14 NPIPB6 PDE4B PFN1 PMS2CL RP11-138A9.1 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP5-1115A15.1 SETD1A SLC5A11 TRAF3 TUBG2 UBASH3B XRCC3 ZKSCAN5 |
Average weekly red wine intake |
1.09 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
C18orf8 CTC-498M16.2 |
Handedness (chirality/laterality): Left-handed |
1.00 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ARHGAP27 |
Mood swings |
1.04 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
ARHGAP27 FNBP4 MST1R |
Loneliness, isolation |
1.11 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
C1QTNF4 FNBP4 MTCH2 |
Long-standing illness, disability or infirmity |
1.37 |
3 |
2 |
4.4 |
-0.73 |
2.7e-01 |
DCLRE1B PTPN22 XRCC3 |
Diabetes diagnosed by doctor |
1.50 |
6 |
2 |
4.4 |
-0.34 |
5.1e-01 |
AC074117.10 ATP13A1 FNDC4 HMG20A RP11-138A9.1 RP11-380L11.3 |
Qualifications: nursing, teaching |
1.05 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MST1R |
Mouth/teeth dental problems: Mouth ulcers |
1.33 |
5 |
2 |
4.4 |
-0.42 |
4.8e-01 |
ARHGAP27 CCR5 GSDMB NDUFS2 WNT3 |
Medication for cholesterol |
1.37 |
4 |
3 |
6.7 |
-0.97 |
2.7e-02 |
FNDC4 GCKR RP11-138A9.1 SH2B3 |
Mineral and other dietary supplements |
1.16 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CTC-498M16.2 |
Asthma (self-reported) |
2.18 |
26 |
22 |
48.9 |
0.53 |
7.0e-04 |
AC004041.2 AHI1 BACH2 C11orf10 DEXI ENO1 FADS1 FADS2 GSDMB MED24 MSL1 NDFIP1 PDLIM4 PGAP3 PPP1R32 RIN3 RP1-102E24.8 RP3-388E23.2 RP5-1029K10.2 RP5-1115A15.1 RTF1 SLC22A4 STARD3 THRA UQCRQ ZNF76 |
Medication: Aspirin |
1.18 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
FES |
Medication: Gliclazide |
1.21 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
EHD4 |
Illnesses of father: None of the above (group 1) |
1.14 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
FES |
Smoking status: Current |
1.29 |
4 |
1 |
2.2 |
0.60 |
4.0e-01 |
AATK MAPKAPK5 MTCH2 PPP1R13B |
Forced expiratory volume in 1-second (FEV1), predicted percentage |
1.37 |
13 |
11 |
24.4 |
-0.24 |
4.0e-01 |
ADAMTSL4 ARHGAP27 BCKDK CTD-2033A16.3 FBXO38 ITGAL PGAP3 RIN3 RP11-347C12.2 SETD1A STARD3 STMN3 WNT3 |
Whole body water mass |
1.80 |
81 |
64 |
142.2 |
-0.50 |
1.2e-07 |
AC034220.3 AC074117.10 AK9 BCKDK C18orf8 C6orf106 CASKIN1 CBX7 CCDC126 CCDC92 CDK6 CENPW CNIH4 CORO7 CTC-498M16.2 CUX2 DCAF16 DZIP1 EBPL EIF2S2 FLJ33630 FNDC3B FNDC4 G6PC2 GATAD1 GCKR GNA12 GRLF1 HELLS HOMEZ HSD17B3 IMP3 IPPK KIAA1614 KRIT1 MAN2C1 MAP3K3 MARK3 MAX MEG3 MLXIPL MRPS21 MST1R NFKBIA NOSTRIN NPIPB6 ORAOV1 PARP12 PDLIM4 PIPSL PNKD PPP2R3C PPTC7 PTCH1 RFT1 RIN3 RP11-347C12.1 RP11-347C12.2 RP11-373D23.3 RP11-380L11.3 RP11-73M18.8 RP11-73O6.3 RP13-39P12.3 RPS10 SDCCAG3 SEPT12 SETD1A SH2B3 SLC22A4 SLC39A13 SLC5A11 SLC9A3R2 SMG6 TBX6 TRAF3 UBE4B UBXN2A UQCRQ USP37 WAC-AS1 ZNF76 |
Leg predicted mass (right) |
1.65 |
67 |
55 |
122.2 |
-0.54 |
2.2e-07 |
AC034220.3 AC074117.10 ADO AK9 ATP13A1 BCKDK C18orf8 C6orf106 CASKIN1 CCDC126 CDK6 CENPW CTC-498M16.2 CUX2 DCAF16 EBPL EHD4 EIF2S2 FLJ33630 FNDC3B FNDC4 G6PC2 GATAD1 GCKR GNA12 GRLF1 HELLS HOMEZ HSD17B3 IPPK KIAA1614 KRIT1 MAP3K3 MARK3 MAX MLXIPL MRPS21 MST1R NFKBIA NOSTRIN NPIPB6 ORAOV1 PARP12 PDLIM4 PIPSL PNKD PPP2R3C PPTC7 PTCH1 RFT1 RIN3 RP11-347C12.1 RP11-347C12.2 RP11-73O6.3 RP13-39P12.3 RPS10 SEPT12 SETD1A SLC22A4 SLC39A13 SLC9A3R2 SMG6 TBX6 TRAF3 TTC19 UQCRQ ZNF76 |
Arm fat mass (left) |
1.40 |
44 |
32 |
71.1 |
0.15 |
3.2e-01 |
ACP2 BCKDK BTBD7 C14orf142 C18orf8 C1QTNF4 C4orf44 C6orf106 CASKIN1 CDK6 CENPO CTC-498M16.2 CTD-2033A16.3 EDEM3 EIF2S2 GFPT1 GNA12 GP1BA GRK4 ITGAL MARS2 MINK1 MST1R MTCH2 NPIPB6 PDE4B PFN1 PPTC7 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP11-73O6.3 RP5-1115A15.1 RPS10 SETD1A SLC5A11 SLC9A3R2 TBX6 TRAF3 TUBG2 UBASH3B XRCC3 ZKSCAN5 |
Number of self-reported non-cancer illnesses |
1.57 |
5 |
3 |
6.7 |
0.93 |
2.4e-02 |
AC074117.10 CYB5D1 FNDC4 RP5-1029K10.2 SH2B3 |
Average weekly champagne plus white wine intake |
1.15 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
C11orf10 FADS1 FADS2 |
Miserableness |
1.15 |
5 |
4 |
8.9 |
-0.60 |
2.8e-01 |
FNBP4 MST1R MTCH2 RNFT1 TTC19 |
Guilty feelings |
1.13 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
UBXN2A |
Eye problems/disorders: Glaucoma |
1.05 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SLC39A13 |
Medication: Blood pressure |
1.41 |
9 |
6 |
13.3 |
0.65 |
4.1e-02 |
ARHGAP27 CMIP CYB5D1 FES HOXC6 PDLIM4 RP11-138A9.1 SH2B3 VPS9D1 |
High cholesterol (Self-reported) |
1.74 |
11 |
9 |
20.0 |
0.16 |
5.8e-01 |
ABO AC074117.10 ATP13A1 C4orf44 FNDC4 GCKR NRBP1 PVRL2 SIDT2 TIMD4 TSEN2 |
Medication: Bendroflumethiazide |
1.26 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
FES PDLIM4 |
Medication: Paracetamol |
1.01 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ARHGAP27 |
Medication: Atorvastatin |
1.42 |
4 |
3 |
6.7 |
0.22 |
7.2e-01 |
ABO AC074117.10 FNDC4 PVRL2 |
Illnesses of father: High blood pressure |
1.10 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
FES |
Ever smoked |
1.13 |
3 |
1 |
2.2 |
0.66 |
3.4e-01 |
PDE4B PHTF1 PTPN22 |
Basal metabolic rate |
1.70 |
69 |
59 |
131.1 |
-0.46 |
1.1e-05 |
AC034220.3 AC074117.10 AK9 BCKDK C18orf8 C6orf106 CASKIN1 CBX7 CCDC126 CDK6 CENPW CNIH4 CORO7 CTC-498M16.2 CUX2 DCAF16 EBPL EIF2S2 FLJ33630 FNDC3B FNDC4 G6PC2 GATAD1 GCKR GNA12 GRLF1 HOMEZ HSD17B3 IPPK KIAA1614 KRIT1 MAP3K3 MARK3 MAX MEG3 MLXIPL MRPS21 MST1R NFKBIA NOSTRIN NPIPB6 ORAOV1 PARP12 PDLIM4 PNKD PPP2R3C PPTC7 PTCH1 RFT1 RIN3 RP11-347C12.1 RP11-347C12.2 RP11-373D23.3 RP11-380L11.3 RP11-73O6.3 RP13-39P12.3 RPS10 SDCCAG3 SEPT12 SETD1A SH2B3 SLC22A4 SLC39A13 SLC5A11 SLC9A3R2 SMG6 TBX6 TRAF3 ZNF76 |
Leg fat percentage (left) |
1.67 |
49 |
35 |
77.8 |
0.48 |
3.1e-04 |
ACP2 BCKDK C14orf142 C18orf8 C1QTNF4 C4orf44 C6orf106 CALCRL CCDC92 CDK5RAP3 CENPO CENPW CTC-498M16.2 CTD-2033A16.3 DCAF16 EDEM3 EIF2S2 FLJ33630 FNBP4 GP1BA GRK4 GSK3A HELLS HSD17B3 MINK1 MST1R MTCH2 NOP14 NPIPB6 PDE4B PMS2CL PPTC7 RIN3 RP11-214K3.24 RP11-347C12.2 RP11-380L11.3 RP5-1115A15.1 RSPH10B2 SETD1A SIDT2 SLC39A13 SLC5A11 SLC9A3R2 TRAF3 UBASH3B WWP1 ZHX3 ZKSCAN5 ZNF12 |
Arm fat-free mass (left) |
1.75 |
67 |
55 |
122.2 |
-0.40 |
2.0e-04 |
ABO AC034220.3 AC074117.10 ADAM1A AK9 BCKDK C18orf8 C6orf106 CASKIN1 CBX7 CCDC126 CCDC92 CDK6 CENPW CNIH4 CORO7 CTC-498M16.2 CUX2 DCAF16 EBPL EIF2S2 FNDC3B FNDC4 G6PC2 GATAD1 GCKR GNA12 GRLF1 IPPK KIAA1614 KRIT1 MAP3K3 MARK3 MAX MEG3 MLXIPL MRPS21 MST1R NFKBIA NOSTRIN PARP12 PDLIM4 PNKD PPP2R3C PPTC7 PTCH1 RFT1 RIN3 RP11-347C12.1 RP11-347C12.2 RP11-373D23.3 RP11-380L11.3 RP11-73O6.3 RP13-39P12.3 RPS10 SDCCAG3 SETD1A SH2B3 SLC22A4 SLC5A11 SLC9A3R2 SMG6 TBX6 TRAF3 UBXN2A VPS29 ZNF76 |
Number of operations (self-reported) |
1.06 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CCDC126 |
Average weekly beer plus cider intake |
1.03 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
MST1R NRBF2 |
Irritability |
0.97 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
ARHGAP27 C11orf10 SETD1A |
Risk taking |
1.07 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
CGREF1 PPP1R13B RP11-73M18.8 |
Ever had prostate specific antigen (PSA) test |
1.21 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP11-299H21.1 |
Diastolic blood pressure, automated reading |
1.47 |
31 |
23 |
51.1 |
0.53 |
1.1e-03 |
ABO AC010883.5 ADAM1A ARHGAP42 ATF1 BCKDK CERS5 CMIP DCAF16 ERAP2 FES FLNB HAUS8 MST1R NRBF2 PPTC7 RP3-462E2.5 RP5-1029K10.2 RP5-1115A15.1 SETD1A SH2B3 SLC39A13 SLC9A3R2 STMN3 STXBP5 TIE1 TMEM116 TMEM87B UBASH3B VPS29 ZNF785 |
Myopia |
1.20 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
FADS2 |
Vascular/heart problems diagnosed by doctor |
1.58 |
27 |
20 |
44.4 |
-0.47 |
1.0e-02 |
ABO ACP2 ADAM1A ARHGAP42 BCKDK CMIP DCAF16 EDEM3 FES FTH1P20 HAUS8 HOXC6 LA16c-358B7.3 MOBP NEK10 NRBF2 PDLIM4 RP3-462E2.5 RP5-1029K10.2 RP5-1115A15.1 SETD1A SH2B3 SLC39A13 SLC5A11 SMG6 TMEM116 UBE2E3 |
Cholesterol lowering medication |
1.60 |
9 |
6 |
13.3 |
-0.13 |
7.0e-01 |
ABO AC074117.10 FNDC4 GCKR PVRL2 RP11-138A9.1 RP11-380L11.3 SIDT2 SSH2 |
Pain experienced in last month |
1.03 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
BCKDK CENPW MST1R |
Basal cell carcinoma (self-reported) |
1.17 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
CASP10 CDKN2B VPS9D1 |
Heart attack/myocardial infarction (self-reported) |
1.40 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
FES |
Deep venous thrombosis (DVT) (self-reported) |
2.07 |
4 |
3 |
6.7 |
-1.00 |
4.9e-06 |
ABO CACFD1 SARDH SURF6 |
Heart disease (siblings) |
1.20 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
FES LIPA |
Pack years of smoking |
1.11 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
XRCC3 |
Impedance of whole body |
1.29 |
50 |
38 |
84.4 |
0.20 |
1.2e-01 |
AC074117.10 ADCK3 ARHGAP27 ATF1 BCKDK C6orf106 CCDC92 CENPW CERS5 CORT CTC-498M16.2 EBPL EHD4 EIF2S2 FLJ33630 FNDC4 GCKR GRLF1 HAUS8 HEATR3 HELLS HMG20A HOXC6 KAT2B LARP4 LIMK2 MARS2 MLXIPL MRPS21 MST1R NRBF2 ORAOV1 PAM PIPSL PPP2R3C PRUNE RCN2 RIN3 RMI1 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP11-429P3.3 RP11-73O6.3 RP5-1029K10.2 RPS10 RPS6KB1 SMG6 TSHR ZNF292 |
Leg fat mass (left) |
1.47 |
46 |
32 |
71.1 |
0.22 |
1.3e-01 |
ACP2 BCKDK BTBD7 C14orf142 C18orf8 C1QTNF4 C4orf44 C6orf106 CASKIN1 CDK6 CENPO CTC-498M16.2 CTD-2033A16.3 EDEM3 EIF2S2 FLJ33630 GFPT1 GP1BA GRK4 ITGAL MEG3 MINK1 MST1R MTCH2 NPIPB6 PDE4B PPTC7 RABEP1 RP11-214K3.24 RP11-347C12.1 RP11-347C12.2 RP11-380L11.3 RP11-73O6.3 RP5-1115A15.1 RPS10 RSPH10B2 SETD1A SLC5A11 SLC9A3R2 TBX6 TRAF3 TUBG2 UBASH3B ZHX3 ZKSCAN5 ZNF12 |
Arm predicted mass (left) |
1.76 |
68 |
52 |
115.6 |
-0.40 |
1.8e-04 |
ABO AC034220.3 AC074117.10 ADAM1A BCKDK C18orf8 C6orf106 CASKIN1 CBX7 CCDC126 CCDC92 CDK6 CENPW CMIP CNIH4 CORO7 CTC-498M16.2 CUX2 DCAF16 EBPL EIF2S2 FNDC3B FNDC4 G6PC2 GATAD1 GCKR GNA12 GRLF1 HELLS IPPK KIAA1614 KRIT1 MAP3K3 MARK3 MAX MEG3 MLXIPL MRPS21 MST1R NFKBIA NOSTRIN ORAOV1 PARP12 PDLIM4 PIPSL PNKD PPP2R3C PPTC7 PTCH1 RFT1 RIN3 RP11-347C12.1 RP11-347C12.2 RP11-373D23.3 RP11-380L11.3 RP11-73O6.3 RP13-39P12.3 RPS10 SETD1A SH2B3 SLC22A4 SLC5A11 SLC9A3R2 SMG6 TRAF3 UBXN2A VPS29 ZNF76 |